IRIS
LIUZZI, Grazia Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.836
AS - Asia 3.251
EU - Europa 3.007
SA - Sud America 790
AF - Africa 220
Continente sconosciuto - Info sul continente non disponibili 213
OC - Oceania 8
Totale 16.325
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.625
SG - Singapore 1.324
IT - Italia 1.066
CN - Cina 817
BR - Brasile 647
HK - Hong Kong 421
SE - Svezia 388
DE - Germania 286
RU - Federazione Russa 258
FR - Francia 254
UA - Ucraina 250
FI - Finlandia 194
VN - Vietnam 168
GB - Regno Unito 128
IN - India 120
CI - Costa d'Avorio 118
BD - Bangladesh 103
CA - Canada 96
AR - Argentina 48
IQ - Iraq 43
TR - Turchia 38
PK - Pakistan 32
ZA - Sudafrica 32
BE - Belgio 28
NL - Olanda 28
MX - Messico 26
CO - Colombia 25
VE - Venezuela 25
ID - Indonesia 22
IE - Irlanda 21
PH - Filippine 21
PL - Polonia 21
MA - Marocco 20
JP - Giappone 19
ES - Italia 18
SA - Arabia Saudita 14
EC - Ecuador 13
UZ - Uzbekistan 13
AT - Austria 12
CR - Costa Rica 12
NI - Nicaragua 12
CL - Cile 11
GT - Guatemala 11
IR - Iran 11
AE - Emirati Arabi Uniti 10
HN - Honduras 10
JM - Giamaica 10
TN - Tunisia 10
ET - Etiopia 9
JO - Giordania 9
MY - Malesia 9
AU - Australia 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
OM - Oman 8
LT - Lituania 7
PY - Paraguay 7
SV - El Salvador 7
EG - Egitto 6
PR - Porto Rico 6
PS - Palestinian Territory 6
SN - Senegal 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
KE - Kenya 5
PE - Perù 5
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
GP - Guadalupe 4
KR - Corea 4
LB - Libano 4
NP - Nepal 4
PT - Portogallo 4
RS - Serbia 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
DK - Danimarca 3
EE - Estonia 3
GE - Georgia 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
MD - Moldavia 3
PA - Panama 3
BB - Barbados 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
LV - Lettonia 2
MN - Mongolia 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BM - Bermuda 1
Totale 16.097
Salva come PNG Salva come JPEG
Città #
Ashburn 855
San Jose 697
Woodbridge 672
Singapore 648
Fairfield 606
Chandler 604
Jacksonville 565
Hong Kong 417
Houston 415
Milan 362
Ann Arbor 333
Nyköping 315
Wilmington 245
Seattle 244
Cambridge 227
Beijing 224
Council Bluffs 200
Rome 140
New York 131
Lawrence 127
Roxbury 126
Abidjan 118
Lauterbourg 117
Nanjing 110
Bari 109
Boardman 102
Marseille 99
Los Angeles 87
Santa Clara 80
Des Moines 79
Columbus 75
Dallas 70
São Paulo 63
Ho Chi Minh City 59
Brooklyn 57
Inglewood 56
Helsinki 45
Munich 43
Princeton 40
Buffalo 39
Jiaxing 37
Hanoi 35
Falkenstein 34
Shenyang 34
Chicago 30
Nanchang 29
Toronto 28
Turku 28
Moscow 27
San Diego 27
Brussels 26
Changsha 25
Guangzhou 25
London 25
Figino 24
Hebei 24
Turin 23
Baghdad 22
Denver 22
Dublin 22
Atlanta 21
Montreal 21
Shanghai 21
San Francisco 20
Belo Horizonte 19
Dhaka 19
Rio de Janeiro 19
Frankfurt am Main 18
Phoenix 18
Amsterdam 17
Palermo 17
Tianjin 17
Warsaw 17
Washington 17
Chennai 16
Leawood 16
Leverano 16
Orem 16
Tokyo 16
Da Nang 15
Dearborn 15
Spongano 15
Curitiba 14
Wuhan 14
Auburn Hills 13
Jakarta 13
Naples 13
Paris 13
Caracas 12
Johannesburg 12
Lahore 12
Managua 12
Monmouth Junction 12
Mumbai 12
Nuremberg 12
Pune 12
Tashkent 12
Bologna 11
Campinas 11
Falls Church 11
Totale 10.755
Salva come PNG Salva come JPEG
Nome #
FAD synthase deficiency: a severe mitochondrial myopathy involving a secondary reduction of RFVT2 expression 239
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 217
FAD synthesis and degradation in the nucleus create a local flavin cofactor pool 207
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 204
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 188
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta 187
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 184
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 164
A thermodynamic and structural study of myelin basic protein in lipid membrane models 163
Biological variations in a long-term ex situ cultivation: a Mediterranean demosponge as model system 159
Retrograde response to mitochondrial dysfunctions associated to LOF variations in FLAD1 exon 2: unraveling the importance of RFVT2 157
A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains 157
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 155
Aquaporin-4-containing astrocytes sustain a temperature- and mercury-insensitive swelling in vitro 153
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 151
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 150
BLOOD MMP-9 AND SICAM-1 AS MARKERS OF RIFN-B TREATMENT EFFICACY IN RELAPSING-REMITTING MS 149
Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis 147
Autoimmune Myelofibrosis: report of three cases and review of the literature 146
Native Myelin Proteins and Myelin Assembly in the Central Nervous System 144
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 143
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 143
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 142
Anti-endothelial cell antibodies (AECA) in a patient wiyh Takayasu’s arteritis. In: Pathogenesis and immunotherapy of autoimmune diseases. Final program and abstract book 142
Aids dementia complex. On the relationship between HIV-1 infection, immune-mediated response and myelin damage in the brain 137
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 135
Identification of water-soluble proteases in myelin preparations 134
Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies 134
Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex 134
Recombinant arabidopsis HSP70 sustains cell survival and metastatic potential of breast cancer cells 133
T-cell response to myelin basic protein and lipid-bound myelin basic protein in patients with multiple sclerosis and healthy donors 131
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 130
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 129
ADHESION MOLECULES AND MATRIX METALLOPROTEINASES IN MS: EFFECTS INDUCED BY INTERFERON BETA 129
Different recognition by clostripain of myelin basic protein in the lipid-free and lipid-bound forms 128
Marine pharmacology: Therapeutic targeting of matrix metalloproteinases in neuroinflammation 125
Crystals of P2 myelin protein in lipid-bound form 124
Myelin degrading activity in the CSF of HIV-1-infected patients with neurological diseases 124
New Diagnostic and Therapeutic Options for the Treatment of Multiple Sclerosis 122
Structure-based design of multitargeting ChEs-MAO B inhibitors based on phenyl ring bioisosteres: AChE/BChE selectivity switch and drug-like characterization 121
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes 121
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. 120
Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders 118
May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. 117
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 117
Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases 117
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 116
Detection of cerebrospinal fluid antibodies against myelin basic protein in patients with AIDS dementia complex 115
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 114
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 114
Lipoprotein(a) in the cerebrospinal fluid of neurological patients with blood-cerebrospinal fluid barrier dysfunction 113
The different forms of PNS myelin P0 protein within and outside lipid rafts 112
Decreased levels of serum Gelatinase B in MS patients treated with rIFN-beta-1b 112
Laminar order within Langmuir-Blodgett multilayers from phospholipid and myelin basic protein: a neutron reflectivity study 111
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 111
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 110
Purification of bovine P2 myelin protein with bound lipids 110
Detection of serum levels and intrathecal synthesis of matrix metallo proteinase-9 in relapsing-remitting multiple sclerosis 109
CHANGES OF SERUM SOLUBLE ICAM-1 AND MATRIX METALLOPROTEINASE-9 DURING INTERFERON BETA-1B TREATMENT IN RR MS 109
Oral administration of nucleotides in calves: Effects on oxidative status, immune response, and intestinal mucosa development 108
Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity 108
Autoimmune bone marrow fibrosis: a distinct clinicopathological entity 107
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 107
Meccanismi di demielinizzazione in pazienti con neuroAIDS 106
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 106
Aumento dell’attività della Gelatinasi B nel liquor di pazienti HIV-positivi con malattie neurologiche del Sistema Nervoso Centrale 106
Meccanismo molecolare di “Swelling” in astrociti in coltura 106
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 106
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 105
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 105
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 105
Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes 104
CEREBROSPINAL FLUID MARKERS FOR THE MONITORING OF AIDS DEMENTIA COMPLEX SEVERITY: USEFULNESS OF ANTI-MYELIN BASIC PROTEIN ANTIBODY DETECTION 103
Bioassay-guided identification of bioactive protein compounds from the Mediterranean demosponge Tethya meloni 103
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 102
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 101
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 101
Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form 101
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 100
Increased Gelatinase B Activity in the CSF of Patients with HIV-Associated Neurological Diseases 100
Antioxidant Compounds from Edible Mushrooms as Potential Candidates for Treating Age-Related Neurodegenerative Diseases 99
Determinazione degli Anticorpi Liquorali Anti-MBP per la Diagnosi di Danno Mielinico in Pazienti con AIDS Dementia Complex 99
Evaluation of Cell Toxicity and Matrix Metalloproteinase-9 Inhibition by combination of Antiretroviral Drugs in Cultured Primary Astrocytes. Implication for the treatment of neuroAIDS. 99
Intrathecal synthesis of matrix metalloproteinase (MMP)-9 in patients with relapsing-remitting (RR) multiple sclerosis (MS) 98
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 98
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis 95
Matrix Metalloproteinases in CNS Inflammation. 94
CNS Myelin Proteins in Lipid-Bound Native Form as Tools for Study, Detection and Treatment of Multiple Sclerosis 94
Ruolo delle proteasi nell’induzione e nella patogenesi della sclerosi multipla 93
Resveratrol impinges on retrograde communication without inducing mitochondrial biogenesis in aged rat soleus muscle 92
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 92
Il ruolo delle proteasi nell’induzione e nella patogenesi della Sclerosi Multipla 92
Follow-up of myelin damage in HIV-associated cryptococcal meningitis. First evidence of anti-myelin basic protein antibodies in the cerebrospinal fluid 91
null 91
null 90
Purification of lipid-associated basic protein from guinea pig spinal-cord myelin 90
Matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 in plasma of patients co-infected with HCV and HIV 90
In vitro cell toxicity and Matrix Metalloproteinase-9 inhibition by antiretroviral drugs in cultured primary astrocytes 90
Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice 90
Demyelination and cerebral toxoplasmosis in HIV-infected patients 89
Totale 12.283
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.412
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022659 0 0 0 24 33 51 32 47 57 55 158 202
2022/20231.675 197 138 106 170 216 213 13 187 347 36 25 27
2023/2024551 44 97 23 120 46 118 7 6 6 14 10 60
2024/20252.239 130 41 197 60 66 134 183 181 96 104 297 750
2025/20265.162 678 269 300 493 515 264 504 120 604 497 228 690
2026/20271.376 171 280 415 510 0 0 0 0 0 0 0 0
Totale 16.325